XML 50 R37.htm IDEA: XBRL DOCUMENT v3.23.1
LOSS PER SHARE
12 Months Ended
Dec. 31, 2022
LOSS PER SHARE  
LOSS PER SHARE

29.   LOSS PER SHARE

A reconciliation of net loss attributable to the Company in the consolidated statements of comprehensive loss to the numerator for the computation of basic and diluted loss per share for the years ended December 31, 2020, 2021 and 2022 is as follows:

For the Years Ended December 31, 

2020

2021

2022

2022

    

RMB

    

RMB

    

RMB

    

US$

Net loss attributable to Concord Medical Services Holdings Limited

 

(309,989)

 

(271,427)

 

(489,661)

(70,993)

Accretion of contingently redeemable noncontrolling interests

 

(359,920)

 

(549,194)

 

Numerator for EPS computation

 

(669,906)

 

(820,621)

 

(489,661)

(70,993)

For the Years Ended December 31

2020

2021

2022

2022

    

Class A

    

Class B

    

Class A

    

Class B

    

Class A

    

Class A

    

Class B

    

Class B

RMB

RMB

RMB

RMB

RMB

USD

RMB

USD

Numerator

    

  

    

  

    

  

    

  

    

  

    

  

Net loss attributable to ordinary shareholders used in calculating loss per ordinary share – basic and diluted

 

(435,855)

(234,054)

(533,909)

(83,784)

(318,582)

(46,189)

(171,079)

(24,804)

Denominator:

 

 

 

Weighted average number of ordinary shares outstanding used in calculating loss per share – basic and diluted

 

85,265,910

45,787,948

 

85,265,910

 

85,265,910

85,265,910

85,265,910

45,787,948

45,787,948

Loss per share – basic and diluted

 

(5.11)

(5.11)

(6.26)

(0.98)

(3.74)

(0.54)

(3.74)

(0.54)

The effects of share options and restricted shares have been excluded from the computation of diluted loss per share for the years ended December 31, 2020, 2021 and 2022 as their effects would be anti-dilutive.